NASDAQ
ATEC

Alphatec Holdings Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Alphatec Holdings Inc Stock Price

Vitals

Today's Low:
$13.79
Today's High:
$14.82
Open Price:
$14.61
52W Low:
$5.73
52W High:
$17.13
Prev. Close:
$14.78
Volume:
1245874

Company Statistics

Market Cap.:
$1.82 billion
Book Value:
-0.514
Revenue TTM:
$389.04 million
Operating Margin TTM:
-32.36%
Gross Profit TTM:
$233.06 million
Profit Margin:
-39.34%
Return on Assets TTM:
-14.07%
Return on Equity TTM:
-993.01%

Company Profile

Alphatec Holdings Inc had its IPO on 2006-06-02 under the ticker symbol ATEC.

The company operates in the Healthcare sector and Medical Devices industry. Alphatec Holdings Inc has a staff strength of 705 employees.

Stock update

Shares of Alphatec Holdings Inc opened at $14.61 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $13.79 - $14.82, and closed at $13.93.

This is a -5.75% slip from the previous day's closing price.

A total volume of 1,245,874 shares were traded at the close of the day’s session.

In the last one week, shares of Alphatec Holdings Inc have slipped by -14.28%.

Alphatec Holdings Inc's Key Ratios

Alphatec Holdings Inc has a market cap of $1.82 billion, indicating a price to book ratio of 91.7569 and a price to sales ratio of 3.568.

In the last 12-months Alphatec Holdings Inc’s revenue was $389.04 million with a gross profit of $233.06 million and an EBITDA of $-82330000. The EBITDA ratio measures Alphatec Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Alphatec Holdings Inc’s operating margin was -32.36% while its return on assets stood at -14.07% with a return of equity of -993.01%.

In Q1, Alphatec Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 53.8%.

Alphatec Holdings Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-1.46 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alphatec Holdings Inc’s profitability.

Alphatec Holdings Inc stock is trading at a EV to sales ratio of 4.0471 and a EV to EBITDA ratio of -11.7318. Its price to sales ratio in the trailing 12-months stood at 3.568.

Alphatec Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$569.69 million
Total Liabilities
$142.90 million
Operating Cash Flow
$-16816000.00
Capital Expenditure
$16.82 million
Dividend Payout Ratio
0%

Alphatec Holdings Inc ended 2024 with $569.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $569.69 million while shareholder equity stood at $-58362000.00.

Alphatec Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $142.90 million in other current liabilities, 12000.00 in common stock, $-975853000.00 in retained earnings and $47.92 million in goodwill. Its cash balance stood at $116.70 million and cash and short-term investments were $116.70 million. The company’s total short-term debt was $20,864,000 while long-term debt stood at $419.46 million.

Alphatec Holdings Inc’s total current assets stands at $299.15 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $62.42 million compared to accounts payable of $39.07 million and inventory worth $108.24 million.

In 2024, Alphatec Holdings Inc's operating cash flow was $-16816000.00 while its capital expenditure stood at $16.82 million.

Comparatively, Alphatec Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$13.93
52-Week High
$17.13
52-Week Low
$5.73
Analyst Target Price
$19.72

Alphatec Holdings Inc stock is currently trading at $13.93 per share. It touched a 52-week high of $17.13 and a 52-week low of $17.13. Analysts tracking the stock have a 12-month average target price of $19.72.

Its 50-day moving average was $16.32 and 200-day moving average was $14.66 The short ratio stood at 5.98 indicating a short percent outstanding of 0%.

Around 3025.6% of the company’s stock are held by insiders while 5173.4% are held by institutions.

Frequently Asked Questions About Alphatec Holdings Inc

The stock symbol (also called stock or share ticker) of Alphatec Holdings Inc is ATEC

The IPO of Alphatec Holdings Inc took place on 2006-06-02

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$3439.25
-256.4
-6.94%
$377
-16.8
-4.27%
$1.21
0.01
+0.83%
$0.3
0.01
+3.21%
$18.3
-2.3
-11.17%
$1487.75
-53.95
-3.5%
$0.02
0
+0.98%
$652.7
-19.05
-2.84%
$7.27
0
0%
$306.95
-36
-10.5%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Address

1950 Camino Vida Roble, Carlsbad, CA, United States, 92008